The Chase Group Executive Search Logo
“Committed to Excellence in Life Sciences Executive Search”

Recent News

Eli Lilly Retains The Chase Group

April 17, 2014
The search has begun for a thoracic expert to join the medical affairs team at Eli Lilly, and the company has entrusted this focused endeavor… Continue Reading →

The Chase Group and Eli Lilly Oncology Business Unit Continue Successful Collaboration

March 31, 2014
TCG completed another successful recruitment for Eli Lilly with the recent placement of an MD/PhD gastrointestinal expert into their medical affairs organization. Continue Reading →

Isis and The Chase Group Work Together Again

March 13, 2014
The Chase Group and Isis Pharmaceuticals are working together to recruit an Associate Director/Director of Quality Control. TCG understands the critical importance of finding a… Continue Reading →

Chase Retained to Recruit Clinical Leadership Position in Immunology

March 7, 2014
Isis Pharmaceuticals has enlisted The Chase Group to fill the Executive Director of Clinical Development, Immunology position. Continue Reading →

Durata Therapeutics Engages The Chase Group

February 7, 2014
The Chase Group has been retained by Durata Therapeutics to begin searching for the Vice President of Clinical Development position. TCG welcomes the opportunity to… Continue Reading →

Another Successful Placement at Isis

December 31, 2013
The Chase Group announces the recruitment of Dr. Andres Digenio to their Executive Director of Clinical Development, Cardiology/Metabolic position at Isis Pharmaceuticals. Continue Reading →

TCG and Isis Partnership Results in Recruitment of Neurologist

December 31, 2013
Dr. Roger Lane was successfully recruited by The Chase Group to join Isis Pharmaceuticals as the new Vice President of Clinical Development in Neurology. Continue Reading →

AbbVie Gains Top Talent

December 16, 2013
AbbVie recently hired two outstanding candidates identified by The Chase Group. Susan Sciotto-Brown joined AbbVie in their R&D facility in Worcester, Massachusetts and has assumed… Continue Reading →

Successful Conclusion to Search for Rare Disease Specialist

December 11, 2013
After an extensive search, The Chase Group announces the recruitment of Dr. Eugene Schneider for the Executive Director, Clinical Development, Rare Diseases position at Isis… Continue Reading →

ImClone Engages The Chase Group

September 10, 2013
The Chase Group has been retained by ImClone to begin searching for the Senior Director/Associate Vice President lead position for breast cancer clinical development. Continue Reading →
© Copyright 1993-2021 The Chase Group; All Rights Reserved.